Blood rain barrier. J Clin Invest 2000, 106:1489?499. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D: Alzheimer’s illness, normal-pressure hydrocephalus, and senescent modifications in CSF circulatory physiology: a hypothesis. Lancet Neurol 2003, 2:506?11. Zlokovic BV: Clearing amyloid by way of the blood rain barrier. J Neurochem 2004, 89:807?11. Privat A, Jacque C, Bourre JM, Dupouey P, Baumann N: Absence with the key dense line in myelin on the mutant mouse `shiverer’. Neurosci Lett 1979, 12:107?12. Nagaike K, Mikoshiba K, Tsukada Y: Dysmyelination of shiverer mutant mice in vivo and in vitro. J Neurochem 1982, 39:1235?241. Gottschall PE, Yu X, Bing B: Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 1995, 42:335?42. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH: Matrix metalloproteases and their inhibitors are developed by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 2002, 100:103?17. Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, Mehanna A, Risso JJ, Chauvin JP, Fenouillet E, Rivera S, Khrestchatisky M: Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia 2010, 58:344?66. Beems T, Simons KS, Van Geel WJ, De Reus HP, Vos PE, Verbeek MM: Serum- and CSF-concentrations of brain certain proteins in hydrocephalus. Acta Neurochir (Wien) 2003, 145:37?3.56. Abdo WF, van de Warrenburg BP, Munneke M, van Geel WJ, Bloem BR, Kremer HP, Verbeek MM: CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Neurology 2006, 67:474?79. 57. Su E, Bell MJ, Kochanek PM, Wisniewski SR, Bayir H, Clark RS, Adelson PD, Tyler-Kabara EC, Janesko-Feldman KL, Berger RP: Increased CSF concentrations of myelin standard protein after TBI in infants and children: absence of significant impact of therapeutic hypothermia. Neurocrit Care 2012, 17:401?07. 58. Lamers KJ, de Reus HP, Jongen PJ: Myelin fundamental protein in CSF as indicator of illness activity in multiple sclerosis. Mult Scler 1998, 4:124?26. 59. Landry CF, Ellison JA, Pribyl TM, Campagnoni C, Kampf K, Campagnoni AT: Myelin simple protein gene expression in neurons: developmental and regional alterations in protein targeting inside neuronal nuclei, cell bodies, and processes.(S)-RuCl[(p-cymene(BINAP)]Cl Purity J Neurosci 1996, 16:2452?462.SulfoxFluor web 60. Landry CF, Pribyl TM, Ellison JA, Givogri MI, Kampf K, Campagnoni CW, Campagnoni AT: Embryonic expression of your myelin fundamental protein gene: identification of a promoter region that targets transgene expression to pioneer neurons.PMID:28322188 J Neurosci 1998, 18:7315?327. 61. Filipovic R, Zecevic N: Interaction among microglia and oligodendrocyte cell progenitors includes Golli proteins. Ann N Y Acad Sci 2005, 1048:166?74. 62. Harauz G, Ladizhansky V, Boggs JM: Structural polymorphism and multifunctionality of myelin standard protein. Biochemistry 2009, 48:8094?104. 63. Chernoff GF: Shiverer: an autosomal recessive mutant mouse with myelin deficiency. J Hered 1981, 72:128. 64. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB: -Amyloid efflux mediated by p-glycoprotein. J Neurochem 2001, 76:1121?128. 65. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV: LRP/amyloid -peptide interaction mediates differential brain efflux of.